Form 4: Clene Inc. Insider Sells Shares via SymBiosis II, LLC

Reporting person Chidozie Ugwumba sold a total of 19,497 shares of Clene Inc. common stock across three transactions in late April 2026.

Summary

• Chidozie Ugwumba, a 10% owner of Clene Inc., executed sales of common stock held by SymBiosis II, LLC.
• The sales occurred on April 28, 29, and 30, 2026.
• A total of 19,497 shares were sold at prices ranging from $5.63 to $6.08 per share.
• Following these transactions, the reporting person maintains an indirect beneficial ownership of 277,569 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale of shares by a 10% owner is a routine disclosure of beneficial ownership changes.

Positives

• The transactions represent a reduction in position rather than a complete exit, leaving a significant remaining stake of 277,569 shares.

Negatives

• Insider selling activity can sometimes be perceived by the market as a lack of confidence in near-term price appreciation.

Risks

• Market liquidity risks associated with the sale of large blocks of shares.
• Potential negative signaling effect on retail investor sentiment.

Future Outlook

The filing does not provide forward-looking guidance or strategic outlooks, as it is a mandatory disclosure of insider transaction activity.

Industry Context

StockSavvy.ai notes that insider selling is a common occurrence for portfolio rebalancing or liquidity needs and does not necessarily reflect a change in the company's fundamental business trajectory.

Comparison to Industry Standards

• Insider transactions are standard regulatory filings for 10% owners and do not deviate from typical corporate governance reporting requirements.

Related Party Transactions

• The shares were held and sold by SymBiosis II, LLC, an entity associated with the reporting person.

Stakeholder Impact

• Shareholders should note the change in beneficial ownership, though the volume sold is relatively small compared to the total outstanding shares.

Next Steps

• Continued monitoring of future Form 4 filings to track changes in insider holdings.

Key Dates

Keywords

Clene Inc, CLNN, Insider Trading, Form 4, SymBiosis II, Chidozie Ugwumba